Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | First Metatarsophalangeal Joint Implant Options (2019) |
Auteurs : | Michelle L. Butterworth ; Maria Ugrinich |
Type de document : | Article |
Dans : | Clinics in Podiatric Medicine and Surgery (Vol. 36, n° 4, October 2019) |
Article en page(s) : | p. 577-596 |
Note générale : | doi:10.1016/j.cpm.2019.07.003 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Arthroplastie prothétique ; Articulation métatarsophalangienne ; Prothèses et implants |
Résumé : | Evidence-based medicine continues to guide our treatment of patients. Because of the unique characteristics of the 1st MTPJ with its small surface area and the significant amount of multiplanar force that affects it, finding the perfect implant to allow motion and alleviate pain is still the ultimate goal. Although some of the older silastic and other implants may still be providing pain relief and function to patients, most have failed and caused significant bone loss along the way. The HemiCap implants have shown some promise in select patients and may still be a viable option in patients desiring maintenance of 1st MTPJ motion. Unfortunately, the PVA hydrogel implant has not received clinical application here in the United States, as the US FDA approval driving studies have shown. Currently, with the lack of PVA hydrogel implant studies, we do not know the true revision rates and pain scores at 10 years or more. As future research redefines optimal techniques, durability of implants and long-term functional outcomes, new advances, and next-generation products will continue to improve on the safety profile of the implants and, ultimately, patient satisfaction. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S0891842219300503 |